Dr Hikaru Hashimura

Dr Hikaru Hashimura

ENDOCRINOLOGIST
MBBS, FRACP

Dr Hikaru Hashimura has strong and broad interests in all aspects of endocrinology including diabetes, thyroid, adrenal and pituitary disorders, osteoporosis, andrology and endocrine issues in pregnancy, menopause and weight management. 

She has published medical research conducted with some of the top endocrinologists in Australia and continues to pursue excellence in clinical skills adopting an open and transparent communication with her patients. She also encourages the patients’ active participation in their treatment.   

Most importantly, Dr Hashimura embraces a holistic, multi-disciplinary approach that recognizes the importance of mental and physical wellbeing for optimal clinical outcomes.

Originally from Osaka, Japan, Dr Hashimura is the founder and president of Japanese Medical Support Network Melbourne, aiming to improve healthcare delivery to the Japanese community. She is the only Japanese-speaking endocrinologist in Australia and can undertake consultations in Japanese. 

Publications

Hashimura H, Shen J, Fuller PJ, Chee YN, Doery JCG, Chong W, Choy KW, Gwini
SM, Yang J. Saline suppression test to distinguish the primary aldosteronism
subtype – a diagnostic study. Eur J Endocrinol. 2023 Jan 188:1-9.

Samad N, Nguyen HH, Hashimura H, Pasco J, Kotowicz M, Strauss BJ, Ebeling
PR, Milat F, Vincent AJ. Abnormal trabecular bone score, lower bone mineral density

and lean mass in young women with premature ovarian insufficiency are prevented by oestrogen replacement. Front Endocrinol (Lausanne). 2022 May 19;13:860853.

Wang K, Hu J, Yang J, Song Y, Fuller PJ, Hashimura H, He W, Feng Z, Cheng Q,
Du Z, Wang Z, Ma L, Yang S, Li Q. Development and validation of criteria for sparing

confirmatory tests in diagnosing primary aldosteronism. J Clin Endocrinol Metab. 2020 Jul 1;105 (7).

Hashimura H, Shen J, Fuller PJ, Chee YN, Doery JCG, Chong W, Choy KW, Gwini SM, Yang J. Saline suppression tests may predict bilateral subtypes of primary aldosteronism. Clin Endocrinol (Oxf). 2018 Sep;89 (3): 308-313.